Optic Nerve Injury – Drugs In Development, 2024
Powered by
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Optic Nerve Injury – Drugs In Development, 2024 report and make more profitable business decisions.
Optic Nerve Injury or optic neuropathy is a common cause of vision loss occurring as a result of damage to the optic nerve. Optic nerve is a group or bundle of nerve fibers that carry out the communication between the eyes and brain. Trauma can be a common cause or complicated cases of diabetic retinopathy can also cause ONI. Neuroimaging studies are performed to diagnose the condition and patients are presented with blurred or loss of vision, pain, color vision loss. Steroids are first line of therapy followed by surgery and conservative management.
The Optic Nerve Injury drugs in development market research report provide comprehensive information on the therapeutics under development for Optic Nerve Injury, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Optic Nerve Injury and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
Scope
- Therapeutics in Development: Covering 11 molecules, with 11 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Optic Nerve Injury therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Optic Nerve Injury pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Optic Nerve Injury treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
ECM Therapeutics IncKukje Pharmaceutical Industry Co Ltd
Life Biosciences Inc.
NeuroScientific Biopharmaceuticals Ltd
Novoron Bioscience Inc
pH Pharma Co Ltd
Sichuan ZehaTimes Pharmaceutical Co Ltd
Staidson BioPharma Inc
Wuhan Neurophth Biological Technology Ltd
Xintrum Pharmaceuticals Ltd